Daphne Williams

Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist

J.M. Jenkins, Daphne Williams, Yanli Deng et al. · Blood · 2007 · 297 citations

Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: Two single-dose, open-label, randomized-sequence, crossover studies

Daphne Williams, Bin Peng, Christine K. Bailey et al. · Clinical Therapeutics · 2009 · 86 citations

Nutrition, Pharmacology, Healthy Adult Subjects +5

A phase I trial of ispinesib, a kinesin spindle protein inhibitor, with docetaxel in patients with advanced solid tumours

Sarah P. Blagden, L. Rhoda Molife, A Seebaran et al. · British Journal of Cancer · 2008 · 80 citations · Full text

rhBMP‐Collagen Sponges as Osteoinductive Devices: Effects of <i>in Vitro</i> Sponge Characteristics and Protein pI on <i>in Vivo</i> rhBMP Pharmacokinetics

Hasan Uludağ, Daphne Williams, Thomas J. Porter et al. · Annals of the New York Academy of Sciences · 1999 · 78 citations

Tissue Engineering, Engineering, Bone Repair +21

Eltrombopag increases plasma rosuvastatin exposure in healthy volunteers

Alicia J. Allred, Carolyn J. Bowen, Jung Wook Park et al. · British Journal of Clinical Pharmacology · 2011 · 71 citations · Full text